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ABSTRACT
Introduction: This study reports the pediatric epidemiology of respiratory syncytial virus (RSV), infl uenza (IF), parainfl uenza 
(PIV), and adenovirus (ADV) at Hospital de Clínicas de Porto Alegre. Methods: Cases of infection, hospitalizations in intensive 
care units (ICUs), nosocomial infections, and lethality rates were collected from 2007 to 2010. Results: RSV accounted for 
most nosocomial infections. Intensive care units admission rates for ADV and RSV infections were highest in 2007 and 2010. 
During 2008-2009, H1N1 and ADV had the highest ICU admission rates. ADV had the highest fatality rate during 2007-2009. 
Conclusions: Each virus exhibited distinct behavior, causing hospitalization, outbreaks, or lethality.
Keywords: Respiratory viruses. Pediatric patients. Infl uenza A (H1N1) virus.
Respiratory tract infections (RTIs) are a major cause of 
morbidity and mortality in children worldwide1. According to 
World Health Organization data, RTIs account for the deaths of 
approximately 4 million children per year. Two-thirds of these 
deaths occur in infants during the fi rst year of life, and 90% 
occur in developing countries. Viruses are the most common 
causative agents of RTIs and are responsible for a substantial 
percentage of childhood mortality2. Traditionally, the most 
widely researched viruses implicated in RTIs include human 
respiratory syncytial virus (RSV), rhinovirus (RHV), infl uenza 
(IF), parainfl uenza viruses (PIV), and adenovirus (ADV)3. 
These viruses circulate within the community and cause many 
hospitalizations. Viral respiratory nosocomial infections are also 
observed throughout the year. Increased hospitalization rates 
and nosocomial outbreaks can create a major fi nancial burden4.
The importance of respiratory virus surveillance has grown 
over the last 10 years because of the unexpected emergence of 
several new respiratory viruses, including infl uenza A (H5N1), 
severe acute respiratory syndrome (SARS) coronavirus, 
coronavirus NL63, human bocavirus, and infl uenza A virus 
(H1N1)5. Furthermore, the seasonality of some respiratory 
viruses is well established, and viral surveillance and laboratory-
based diagnostics play an important role in guiding the timing of 
prophylaxis and other interventions. However, this seasonality 
may be variable. In temperate regions, for instance, viral 
infections tend to peak in the late fall and winter, whereas in 
tropical regions, they occur over extended periods associated 
with the rainy season6. In Brazil, a continental country that is 
host to many different climates, regional surveillance studies on 
viral patterns play an essential role in the planning of prophylaxis 
programs and other interventions. Thus, this study aimed to 
report the epidemiology of major respiratory viruses (RSV, IF, 
PIV, and ADV) among pediatric patients who were treated at 
Hospital de Clínicas de Porto Alegre (HCPA) between 2007 and 
2010, including data on the 2009 infl uenza A (H1N1) pandemic.
Porto Alegre is the capital of the Brazilian State Rio Grande do 
Sul, which is located at 10m above mean sea level, latitude 30.01 
S, and longitude 51.13 W. It has a mean annual temperature of 
19°C and an area of 497km² with a population of approximately 
1.5 million. Hospital de Clínicas de Porto Alegre is a university-
affi liated tertiary referral hospital with over 800 beds that serves 
the population of Porto Alegre and its metropolitan region. This 
study followed an observational design, and the data on all 
variables were collected from children (age 0-12 years) who 
were treated at HCPA between 2007 and 2010 (retrospective 
study). We obtained the number of cases of respiratory infection 
attributable to each viral agent of interest, the number of patients 
admitted to general wards and intensive care units (ICUs), the 
number of nosocomial infections, and lethality rates. The study 
protocol was approved by the HCPA Research Ethics Committee.
The laboratory detection of viruses (RSV, ADV, IF, and 
PIV) in nasopharyngeal aspirates was performed with an 
indirect immunofl uorescence (IIF) assay using commercially 
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TABLE 1 - Number of confi rmed cases by virus, rate of admission to 
general wards and admission to intensive care unit.
Human respiratory syncytial virus 2007 2008 2009 2010
Human Adenovirus    
N 14 12 14 18
A 8 10 9 14
% 57.1 83.3 64.3 77.8
ICU 2 2 2 2
% 14.3 16.6 14.3 11.1
Infl uenza virus    
N 25 20 105 6
A 5 11 50 4
% 20.0 55.0 47.6 66.7
ICU 2 4 5 0
% 8.0 20.0 4.8 0.0
Infl uenza A (H1N1) virus    
N - - 28 -
A - - 18 -
% - - 64.3 -
ICU - - 7 -
% - - 25.0 -
Parainfl uenza viruses    
N 68 136 105 98
A 23 34 67 60
% 33.8 25 63.8 61.2
ICU 5 7 5 2
% 7.3 5.1 4.8 2.0
Human respiratory syncytial virus    
N 201 296 264 307
A 119 168 157 259
% 59.2 56.7 59.5 84.4
ICU 32 38 25 33
% 15.9 12.8 9.5 10.7
N: number of confi rmed cases by each virus; A: number of cases with 
admission to general wards by each virus; ICU: number of cases with 
admission to intensive care unit. 
available monoclonal antibodies (Medivax, Dublin, Ireland). 
Infl uenza A (H1N1) was detected using real-time polymerase 
chain reaction (PCR) as per the Centers for Disease Control 
and Prevention (CDC) protocol7. This assay was performed in 
Brazilian reference laboratories.
The number of IIF-confi rmed cases of infection with each 
respiratory virus of interest (RSV, IF, PIV, and ADV) was 
obtained from HCPA Infection Control Committee reports, as 
was the number of hospitalizations in general wards and ICUs. 
The criteria for nosocomial infection included the absence of 
respiratory symptoms at the time of admission and the detection 
of a respiratory virus within 7 days after admission8. Nosocomial 
infection rates were calculated as the percentage of nosocomial 
infections attributable to each virus divided by the total number 
of nosocomial infections attributable to all viruses x 100.
The number of deaths due to viral respiratory tract infection 
was obtained, and the case lethality rates for each virus were 
calculated. Case lethality was calculated using the formula 
number of deaths/number of cases x 100. All results were 
obtained by descriptive analysis.
Approximately 12,160 pediatric patients were treated per 
year at the HCPA Emergency Department. The Emergency 
Department is the point of entry for the majority of patients 
treated at HCPA. The number of patients treated and the number 
of suspected and confi rmed cases of viral RTIs (due to RSV, 
IF, PIV, and ADV) followed an upward trend during the winter 
months (June to August) of each year (Figure 1).
The number of confi rmed cases stratifi ed by virus and 
severity (admission to general wards or ICUs) is shown in 
Table 1. This table shows that RSV and ADV were responsible 
for the highest rates of ICU admission in 2007 and 2010, 
whereas H1N1 and ADV accounted for the highest rates of ICU 
admission in 2008 and 2009.
Table 2 shows that RSV was responsible for the highest 
rates of nosocomial infection throughout the study period 
(81.5%, 61%, 37.7%, and 53.5% in 2007 through 2010, 
respectively).
The case fatality rates observed in 2007 through 2010, 
respectively, were as follows: ADV = 7.1%, 16.7%, 7.1%, and 
0%; IF = 0%, 5%, 4.7%, and 0%; PIV = 0%, 1.5%, 0.9%, and 0%; 
and RSV = 1.5%, 1.4%, 1.5%, and 2.3%. In 2009, the case fatality 
rate for H1N1 was 7.1%. ADV had the highest case fatality rates. 
In 2009, the case fatality rate of H1N1 was similar to that of ADV.
In temperate regions, the rates of viral infection generally 
tend to increase in the late fall and winter, whereas in tropical 
regions, this increase occurs over extended periods associated 
with the rainy season6. In our study, conducted in Porto Alegre, 
we observed a trend toward increases in the number of confi rmed 
cases of viral infection in the winter months (June to August) of 
each year (Figure 1). A substantial number of RSV and infl uenza 
cases occurred in these months. These viruses, particularly RSV, 
are highly prevalent among children (Table 1). Consequently, 
annual RSV outbreaks lead to increased presentation of 
children to the HCPA Emergency Department. The frequency 
and severity of RSV infections in this age group appear to be 
a consequence of complex and multifactorial events, mainly 
involving immunological factors9. Palivizumab, a humanized 
monoclonal antibody, is currently recommended as prophylaxis 
for certain patient groups at risk of severe RSV infection4. 
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TABLE 2 - Rates of nosocomial infection by respiratory viruses 
(ADV, IF, H1N1, PIV and RSV) in each year (2007-2010).
                                       Nosocomial infections*
Years ADV (%) IF (%) H1N1 (%) PIV (%) RSV (%)
2007 11.0 0.0 0.0 7.0 81.5
2008 12.0 2.0 0.0 24.5 61.0
2009 1.4 29.0 4.0 27.5 37.7
2010 4.6 2.0 0.0 39.5 53.5
ADV: human adenovirus; IF: infl uenza virus; H1N1: infl uenza A 
(H1N1) virus; PIV: parainfl uenza viruses; RSV: human respiratory 
syncytial virus. *nosocomial infection rates were calculated as the 
percentage of nosocomial infections caused by each virus/total 
number of viral nosocomial infections x 100.
Despite its proven efficacy in reducing hospitalizations 
attributable to RSV, palivizumab is still exceedingly expensive 
for developing countries such as Brazil. Therefore, reducing 
costs through the optimization of drug administration may allow 
more children to benefi t from RSV prophylaxis10.
Concerning nosocomial infections, RSV is the foremost 
cause of hospital-acquired respiratory infections among 






































































































































N of children with suspicion of viral infectionumber
Number of confirmed cases











































Number of children with suspicion of viral infection
Number of confirmed cases












































s Number of children with suspicion of viral infection
Number of confirmed cases










































s Number of children with suspicion of viral infection
Number of confirmed cases
Number of patients seen at emergency dept.
FIGURE 1 - Number of patients treated for suspected infection with respiratory virus and confi rmed cases of infection, 2007-2010.
observed in this study are consistent with this information 
(Table 2). However, these rates displayed some variation in 
each year of the study period, and a decrease occurred in 2009. 
This downward trend in 2009 may have been associated with 
the extensive circulation of H1N1 in this period. A similar 
phenomenon was reported by Mak and co-workers in Hong 
Kong and is most likely explained by virus interference11.
Regarding the severity of respiratory infections, using ICU 
admission as a surrogate measure, we observed higher rates of 
ICU admission for RSV and ADV infection in 2007 and 2010, 
whereas in 2008 and 2009, the highest rates of ICU admission were 
attributable to H1N1 and ADV (Table 1). Adenovirus infections 
often lead to severe clinical consequences in hospitalized 
patients12, and these infections are a matter of great concern to the 
members of hospital infection control committees. During 2009, 
H1N1 accounted for a substantial portion of ICU admissions. 
Libster and colleagues also reported higher hospitalization rates 
due to H1N1 infection among Argentinean children. In Argentina, 
the rates of hospitalization for H1N1 were double those for 
seasonal infl uenza in 200813. We observed a similar increase 
in hospitalization rates in our sample, demonstrating that the 
emergence of H1N1 had a major impact on our health system. 
However, RSV can account for even higher ICU admission rates, 
as observed in 2007 and 2010 in this study. These variations 
are most likely associated with circulating RSV genotypes 
and with the extent of the annual RSV outbreak in each year14.
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Our study also assessed the case lethality rates of viral RTIs. 
Mirroring the severity of respiratory infections as measured by 
ICU admission, ADV and H1N1 had the highest case fatality 
rates, as expected. Linch and coworkers reported that ADV 
disease is more severe, and dissemination more likely, in patients 
with impaired immunity12. Because of their severe clinical 
manifestations and ability to start outbreaks, ADV infections are 
kept under close surveillance in the hospital setting. As for H1N1, 
this new emergent strain of infl uenza displayed a distinct severity 
profi le among pediatric patients. Whereas seasonal infl uenza 
had case lethality rates of approximately 5%, the lethality rate of 
H1N1 was 7.1%. Other studies have also noted that infl uenza A 
(H1N1) is associated with substantial pediatric mortality13,15. The 
important tools for minimizing the severity of infection in children 
include antiviral therapy, particularly in patients with preexisting 
neurological disorders or chronic lung disease, and vaccination.
There are some limitations to our study. Virus detection 
(except for H1N1) was evaluated by IIF, which is not a molecular 
test with increased sensitivity. The IIF assay can display low 
sensitivity for ADV and IF detection5. Moreover, the lack of data 
about other respiratory viruses, such as rhinovirus, bocavirus, and 
metapneumovirus, is a limitation in this study. However, this study 
profi led important respiratory viruses in the capital of the Brazilian 
State of Rio Grande do Sul, including data on the H1N1 pandemic.
In summary, each respiratory virus can display a distinct pattern 
of behavior, causing hospitalization, nosocomial outbreaks, or 
even mortality in children. Monitoring and surveillance of well-
known respiratory viruses and unexpected emerging threats 
play an important role in guiding management and minimizing 
the impact on the community. Consequently, viral surveillance 
studies are important to guide the timing of prophylaxis and other 
interve ntions. Surveillance of RSV peaks, for example, helps 
track RSV seasonality and thus supports planning of prophylaxis 
for vulnerable children. Adequate surveillance of infl uenza plays 
a major role in the design of appropriate vaccines, the planning of 
prophylaxis schedules, and the detection of novel viruses. Thus, 
respiratory illness surveillance strategies can reduce healthcare 
costs, morbidity, and mortality.
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